2015
Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia
NOETZLI, Leila; Richard W. LO; Alisa B. LEE-SHERICK; Michael CALLAGHAN; Patrizia NORIS et al.Základní údaje
Originální název
Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia
Autoři
NOETZLI, Leila; Richard W. LO; Alisa B. LEE-SHERICK; Michael CALLAGHAN; Patrizia NORIS; Anna SAVOIA; Madhvi RAJPURKAR; Kenneth JONES; Katherine GOWAN; Carlo L. BALDUINI; Alessandro PECCI; Chiara GNAN; Daniela DE ROCCO; Michael DOUBEK; Ling LI; Lily LU; Richard LEUNG; Carolina LANDOLT-MARTICORENA; Stephen HUNGER; Paula HELLER; Arthur GUTIERREZ-HARTMANN; Xiayuan LIANG; Fred G. PLUTHERO; Jesse W. ROWLEY; Andrew S. WEYRICH; Walter H.A. KAHR; Christopher C. PORTER a Paola DI JORGE
Vydání
Nature genetics, New York, Nature Publishing Group, 2015, 1061-4036
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30200 3.2 Clinical medicine
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 31.616
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/15:00083395
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
acute lymphoblastic leukemia; alternative RNA splicing; amino acid substitution;
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 15. 7. 2015 17:19, Soňa Böhmová
Anotace
V originále
Some familial platelet disorders are associated with predisposition to leukemia, myelodysplastic syndrome (MDS) or dyserythropoietic anemia(1,2). We identified a family with autosomal dominant thrombocytopenia, high erythrocyte mean corpuscular volume (MCV) and two occurrences of B cell-precursor acute lymphoblastic leukemia (ALL). Whole-exome sequencing identified a heterozygous single-nucleotide change in ETV6 (ets variant 6), c.641C>T, encoding a p.Pro214Leu substitution in the central domain, segregating with thrombocytopenia and elevated MCV. A screen of 23 families with similar phenotypes identified 2 with ETV6 mutations. One family also had a mutation encoding p.Pro214Leu and one individual with ALL. The other family had a c.1252A>G transition producing a p.Arg418Gly substitution in the DNA-binding domain, with alternative splicing and exon skipping. Functional characterization of these mutations showed aberrant cellular localization of mutant and endogenous ETV6, decreased transcriptional repression and altered megakaryocyte maturation. Our findings underscore a key role for ETV6 in platelet formation and leukemia predisposition.